Analgesic mechanism of Panaphix in spinal nerve-ligated rats: involvement of microglial inflammatory cytokines
Myong-Hwan Karm, Hyun-Jung Kwon, Doo-Hwan Kim, Jun-Seok Lee, Minsu Han, Eun Ha Kim, Chan-Sik Kim, Jin-Woo Shin, Seong-Soo Choi · 2026
Read Analgesic mechanism of Panaphix in spinal nerve-ligated rats: involvement of microglial inflammatory cytokines by Myong-Hwan Karm, Hyun-Jung Kwon, Doo-Hwan Kim, Jun-Seok Lee, Minsu Han, Eun Ha Kim, Chan-Sik Kim, Jin-Woo Shin, Seong-Soo Choi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624826.txt.
Description
Myong-Hwan Karm and co-authors study how a new drug, Panaphix, eases nerve pain in rats, in this 2026 Europe PMC paper. Neuropathic pain follows nerve damage and resists standard painkillers. The model used spinal nerve ligation, a surgical injury that produces lasting sensitivity to touch.
Rats received the drug by mouth daily for a week at three doses. Touch sensitivity eased in step with dose, and a middle dose was chosen for deeper analysis. The drug sharply lowered one inflammatory signal, IL-1 beta, in microglia, and partly lowered another in nerve tissue. Effects on astrocyte signals were minimal. The results point to microglial inflammation as the drug's main target.
Catalog record
| CREATOR | Myong-Hwan Karm, Hyun-Jung Kwon, Doo-Hwan Kim, Jun-Seok Lee, Minsu Han, Eun Ha Kim, Chan-Sik Kim, Jin-Woo Shin, Seong-Soo Choi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |